A new Chinese-made vaccine emerged from late-stage clinical trials this week, well-positioned to help overcome a number of the obstacles that have hampered large-scale distribution of COVID-19 jabs to the world’s poorest countries, including many in Africa.
- Get a daily email packed with the latest China-Africa news and analysis.
- Read exclusive insights on the key trends shaping China-Africa relations.
- Connect with leading professionals on the China- Africa Experts Network.